Values First Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Values First Advisors's RPRX Position: Q2 2026 in Review
Values First Advisors increased its Royalty Pharma (RPRX) stake by 1.1% in Q2 2026, buying an estimated $12.2K and bringing the position to 21,005 shares worth $1.18M. The position accounts for 0.54% of the portfolio, ranked #58.
Values First Advisors first reported a position in RPRX in Q1 2023 and has held it in 12 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Values First Advisors held 21,005 shares of Royalty Pharma worth $1.18M as of Q2 2026.
- Values First Advisors bought 234 Royalty Pharma shares in Q2 2026, an estimated $12.2K.
- Royalty Pharma made up 0.54% of Values First Advisors's portfolio in Q2 2026, its #58 holding.
- Values First Advisors first reported a position in Royalty Pharma in Q1 2023 and has held it in 12 quarters since.
- 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Values First Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.